Mammen P. Mammen
Nessuna posizione attualmente
Storia della carriera di Mammen P. Mammen
Precedenti posizioni note di Mammen P. Mammen
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| INOVIO PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 25/06/2020 | 01/01/2022 |
| Walter Reed Army Institute of Research | Corporate Officer/Principal | - | - |
Vical, Inc.
 Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA. | Direttore Tecnico/Scientifico/R&S | 01/05/2017 | - |
| Corporate Officer/Principal | 07/11/2012 | 01/05/2017 |
Formazione di Mammen P. Mammen
| The Pennsylvania State University | Doctorate Degree |
| Williams College | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 6 |
Posizioni
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| INOVIO PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Vical, Inc.
Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA. | Health Technology |
| Walter Reed Army Institute of Research |
- Borsa valori
- Insiders
- Mammen P. Mammen
- Esperienza
